# US 11,076,984 B2 · Method of performing subretinal drainage and agent delivery > Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt - Number: US 11,076,984 B2 - Document ID: US11076984B2 - Status: Granted - Kind: B2 - Application number: 15/911,315 - Filed: 2018-03-05 - Published: 2018-09-13 - Granted: 2021-08-03 - Earliest claimed: 2017-03-13 - Assignees: Gyroscope Therapeutics Limited - Applicants: Orbit Biomedical Limited - Inventors: Daniel W. Price; Brendan J. Oberkircher; Daniel J. Prenger; Geoffrey King; Isaac J. Khan; Michael F. Keane; Benjamin L. Ko - Web page: https://patentgrep.com/patent/US11076984B2 ## CPC - A61F 9/0017: {implantable in, or in contact with, the eye, e.g. ocular inserts} - A61F 9/0008: {Introducing ophthalmic products into the ocular cavity or retaining products therein (putting in contact lenses A61F9/0061; introducing or retaining media in cavities of the body in general A61M31/00)} - A61F 9/0026: {Ophthalmic product dispenser attachments to facilitate positioning near the eye} - A61F 9/007: Methods or devices for eye surgery - A61F 9/00727: {Apparatus for retinal reattachment} - A61F 9/00736: {Instruments for removal of intra-ocular material or intra-ocular injection, e.g. cataract instruments (A61F9/008 takes precedence)} - A61F 9/00781: {Apparatus for modifying intraocular pressure, e.g. for glaucoma treatment (drainage implants in general A61M27/002)} - A61M 5/158: Needles {for infusions; Accessories therefor, e.g. for inserting infusion needles, or for holding them on the body} - A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C) - A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)} ## Abstract A method includes inserting a flexible cannula between a sclera and a choroid of an eye. The needle is advanced from a distal end of the flexible cannula, such that the needle pierces the choroid to access a subretinal space of the eye. The needle is used to aspirate fluid from the subretinal space. The fluid may be present from a retinal detachment, a macular hemorrhage, or other condition present before the procedure begins. The method may further include injecting the fluid in the subretinal space via the needle, in which case the fluid may be a balanced salt solution or other bleb fluid. The method may further include injecting a therapeutic agent into the subretinal space after aspirating the bleb fluid. The volume of injected bleb fluid may be greater than the volume of injected therapeutic agent. ## Claims ### Claim 1 A method, comprising: (a) inserting a flexible cannula having a needle retracted therein into a space between a sclera and a choroid of an eye; (b) arresting insertion of the flexible cannula into the space between the sclera and the choroid of the eye; (c) after arresting insertion of the flexible cannula, advancing the needle from a distal end of the flexible cannula, such that the needle pierces the choroid to access a subretinal space of the eye; (d) aspirating fluid from the subretinal space via the needle; and (e) after aspirating fluid from the subretinal space via the needle, injecting a therapeutic agent into the subretinal space via the needle. ### Claim 2 (depends on 1) The method of claim 1, further comprises performing a sclerotomy in the sclera to thereby form an incision through the sclera, wherein the act of inserting the flexible cannula into the space between the sclera and the choroid comprises inserting the cannula through the incision. ### Claim 3 (depends on 1) The method of claim 1, further comprising securing a guide assembly to the eye, wherein the act of inserting the flexible cannula into the space between the sclera and the choroid comprises inserting the cannula through the guide assembly. ### Claim 4 (depends on 1) The method of claim 1, wherein the distal end of the flexible cannula includes a transversely oriented opening, wherein the act of advancing the needle comprises advancing the needle out through the transversely oriented opening. ### Claim 5 (depends on 1) The method of claim 1, wherein the needle does not pierce a retina of the eye when the needle is advanced from the distal end of the flexible cannula. ### Claim 6 (depends on 1) The method of claim 1, wherein the fluid is located in the subretinal space of the eye before the act of inserting the flexible cannula is performed. ### Claim 7 (depends on 1) The method of claim 1, wherein the fluid is located in the subretinal space of the eye before the act of advancing the needle is performed. ### Claim 8 (depends on 1) The method of claim 1, wherein the fluid is located in the subretinal space due to a retinal detachment that occurred before the act of inserting the flexible cannula is performed. ### Claim 9 (depends on 1) The method of claim 1, wherein the fluid is located in the subretinal space due to a macular hemorrhage that occurred before the act of inserting the flexible cannula is performed. ### Claim 10 (depends on 1) The method of claim 1, further comprising injecting the fluid into the subretinal space of the eye, wherein the act of injecting the fluid causes a substantial portion of the retina to detach from the choroid. ### Claim 11 (depends on 10) The method of claim 10, wherein the act of injecting the fluid is performed after the act of advancing the needle, wherein the fluid is injected via the needle. ### Claim 12 (depends on 10) The method of claim 10, wherein the fluid comprises a balanced salt solution. ### Claim 13 (depends on 10) The method of claim 10, wherein the act of injecting the fluid into the subretinal space comprises injecting a first volume of fluid into the subretinal space, wherein the act of injecting a therapeutic agent into the subretinal space comprises injecting a second volume of fluid into the subretinal space, wherein the first volume is larger than the second volume. ### Claim 14 (depends on 13) The method of claim 13, wherein the act of aspirating fluid from the subretinal space comprises aspirating the first volume of fluid. ### Claim 15 (depends on 13) The method of claim 13, wherein the first volume is in the range of approximately 150 μL to approximately 400 μL, wherein the second volume is in the range of approximately 25 μL to approximately 200 μL. ### Claim 16 A method, comprising: (a) inserting a flexible cannula between a sclera and a choroid of an eye in an anterior region of the eye; (b) after a distal end of the flexible cannula reaches a posterior region of the eye, advancing a needle from the distal end of the flexible cannula, such that the needle pierces the choroid to access a subretinal space of the eye; (c) injecting a first volume of bleb fluid into the subretinal space via the needle; (d) aspirating at least some of the first volume of bleb fluid from the subretinal space via the needle; and (e) after aspirating at least some of the first volume of bleb fluid from the subretinal space via the needle, injecting a second volume of therapeutic agent into the subretinal space via the needle, wherein the second volume is smaller than the first volume. ### Claim 17 A method, comprising: (a) performing a sclerotomy in an anterior region of a sclera of an eye to thereby form an incision through the sclera; (b) inserting a flexible cannula through the incision into a space between the sclera and a choroid of the eye such that the flexible cannula is oriented tangentially relative to the incision; (c) advancing the flexible cannula within the space to position a distal end of the flexible cannula at a posterior region of a retina of the eye on an opposite side of the choroid from the retina; (d) advancing a needle from a distal end of the flexible cannula, such that the needle pierces the choroid to access a subretinal space of the eye; (e) aspirating a first fluid from the subretinal space via the needle, and (f) after aspirating the first fluid from the subretinal space via the needle, injecting a second fluid into the subretinal space via the needle. ### Claim 18 (depends on 1) The method of claim 1, wherein the act of aspirating fluid from the subretinal space is performed with the needle at a first location in the subretinal space, wherein the act of injecting a therapeutic agent into the subretinal space is performed with the needle at the first location. ### Claim 19 (depends on 1) The method of claim 1, wherein the act of aspirating fluid from the subretinal space comprises aspirating bleb fluid from the subretinal space. ### Claim 20 (depends on 1) The method of claim 1, further comprising after injecting the therapeutic agent into the subretinal space, removing the flexible cannula from the space between the sclera and the choroid of the eye.